Thymosin Alpha-1

What is Thymosin Alpha-1?

Thymosin alpha-1 is a 28-amino-acid peptide your thymus produces naturally, and it is one of the few compounds in this library with a real regulatory footprint. Sold as the synthetic drug Zadaxin (thymalfasin), it is approved in dozens of countries, including China, mainly for chronic hepatitis B and to strengthen vaccine responses. It is not FDA-approved in the US. So this is a genuine, well-characterized single peptide with an approved product behind it, just not domestically.

How Thymosin Alpha-1 works

It works by tuning the immune system rather than attacking a pathogen directly. Thymosin alpha-1 acts on toll-like receptors (notably TLR9) and helps T cells mature and function, which sharpens the body's pathogen-specific response. At the same time it can temper excess inflammation, so the effect is more restoring balance than simply revving things up. That dual character is why it has been explored both in infections, where you want a stronger response, and in inflammatory or immunosuppressed states, where you want a smarter one.

What the research shows

By peptide standards the evidence is substantial. Reviews document dozens of clinical trials involving thousands of people across hepatitis B and C, cancer immunotherapy, sepsis, vaccine enhancement, and more recently COVID-19. In chronic hepatitis B, controlled trials reported meaningfully higher sustained virologic response with thymosin alpha-1 than with control, which is the basis for its approval in that indication. The honest boundary: approval for hepatitis and vaccine support does not validate every use it gets marketed for, and its COVID-19 and general anti-aging claims are far less settled than the hepatitis data.

Dosage and how it is used

In its approved hepatitis B use, Zadaxin is commonly dosed at 1.6 mg subcutaneously twice weekly, and other indications use different schedules. That is prescription dosing set in approved markets, not a validated self-administration regimen, so treat figures outside a clinical setting with corresponding caution.

→ How to reconstitute Thymosin Alpha-1: calculator, units to draw & storage

Side effects and safety

Across its trial history thymosin alpha-1 has been generally well tolerated, with side effects that tend to be mild, such as injection-site reactions. That track record, plus approval in many countries, gives it one of the stronger safety profiles in this library. Even so, it is not FDA-approved in the US, and using it outside a supervised medical setting means you are outside the framework that generated that safety data.

• Research depth: extensive. Dozens of human trials; approved as Zadaxin in many countries.
• Generally well tolerated in trials, most commonly mild injection-site effects.
• Not FDA-approved in the US. Legal status varies by jurisdiction; verify it independently.

Frequently asked questions

References

• Aging and thymosin alpha-1. PMC12692621.
• Thymalfasin (thymosin alpha-1) to treat COVID-19 infection. ClinicalTrials.gov, NCT04487444.